Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Non-Current Deffered Revenue (2011 - 2013)

Verastem (VSTM) posted quarterly Non-Current Deffered Revenue of $16000.0 for Q2 2013, down 71.93% year-over-year from $57000.0 in Q2 2012, and down 42.86% quarter-over-quarter from $28000.0 in Q1 2013.

Analysis

Verastem (VSTM) Non-Current Deffered Revenue (2011 - 2013) Analysis & Trends

Verastem's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $16000.0 for Q2 2013.

  • In Q2 2013, Non-Current Deffered Revenue fell 71.93% year-over-year to $16000.0; the TTM figure through Jun 2013 stood at $16000.0 (down 71.93% YoY), while the FY2012 annual figure was $38000.0, down 48.65% from the prior year.
  • Non-Current Deffered Revenue for Q2 2013 stood at $16000.0, down from $28000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $74000.0 in Q4 2011, with the low at $16000.0 in Q2 2013.
  • The 3-year median for Non-Current Deffered Revenue is $47000.0 (2012), against an average of $46571.4.
  • The sharpest annual moves came in 2012 and 2013: Non-Current Deffered Revenue tumbled 48.65% in 2012, then tumbled 71.93% in 2013.
  • Verastem's Non-Current Deffered Revenue stood at $74000.0 in 2011, then sank by 48.65% to $38000.0 in 2012, then plunged by 57.89% to $16000.0 in 2013.
  • Business Quant data shows VSTM's Non-Current Deffered Revenue at $16000.0 in Q2 2013, $28000.0 in Q1 2013, and $38000.0 in Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 16,000.00
Mar 31, 2013 28,000.00
Dec 31, 2012 38,000.00
Sep 30, 2012 47,000.00
Jun 30, 2012 57,000.00
Mar 31, 2012 66,000.00
Dec 31, 2011 74,000.00